Wellisen Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 9.33 Cr
as on 23-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -42.56%
(FY 2022)
- Profit -127.47%
(FY 2022)
- Ebitda -339.90%
(FY 2022)
- Net Worth -29.06%
(FY 2022)
- Total Assets -6.10%
(FY 2022)
About Wellisen Nutraceuticals
The Corporate was formerly known as V A S Investment Technologic Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Puri and Sujitha Harikrishnan serve as directors at the Company.
- CIN/LLPIN
U36109PN2006PTC214051
- Company No.
147063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2006
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Wellisen Nutraceuticals Private Limited offer?
Wellisen Nutraceuticals Private Limited offers a wide range of products and services, including Dyes & Color Additives, Inorganic Pigment, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Wellisen Nutraceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Puri  | Director | 24-Jul-2013 | Current |
Sujitha Harikrishnan  | Director | 27-Mar-2024 | Current |
Financial Performance of Wellisen Nutraceuticals.
Wellisen Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 42.56% decrease. The company also saw a substantial fall in profitability, with a 127.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellisen Nutraceuticals?
In 2022, Wellisen Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V A S Properties Private LimitedActive 18 years 11 monthsSanjay Puri and Sujitha Harikrishnan are mutual person
- Engage Medical India Private LimitedActive 24 years 10 months
Sanjay Puri and Sujitha Harikrishnan are mutual person
- Kaloupi It Services Private LimitedActive 25 years 11 months
Sanjay Puri and Sujitha Harikrishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellisen Nutraceuticals?
Wellisen Nutraceuticals has a workforce of 1 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellisen Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellisen Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
